National Bank of Canada’s Pulmonx LUNG Stock Holding History

National Bank of Canada’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-489	Closed	-$3.32K	–	3021
2024 Q4	$3.32K	Buy	+489	New	+$3.22K	﹤0.01%	2506

Other funds holding LUNG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada's LUNG Position: Q1 2025 in Review

National Bank of Canada sold out of Pulmonx (LUNG) in Q1 2025, closing a stake of 489 shares — an estimated $3.32K sold.

National Bank of Canada first reported a position in LUNG in Q4 2024 and held it in 1 quarter. The position peaked at $3.32K in Q4 2024. 115 funds tracked by Wall St. Rank hold LUNG as of Q1 2025.

National Bank of Canada reported no remaining Pulmonx position as of Q1 2025 after selling out during the quarter.
National Bank of Canada sold 489 Pulmonx shares in Q1 2025, an estimated $3.32K.
National Bank of Canada first reported a position in Pulmonx in Q4 2024 and held it in 1 quarter.
National Bank of Canada's Pulmonx position peaked at $3.32K in Q4 2024.
115 funds tracked by Wall St. Rank held Pulmonx as of Q1 2025.

Based on National Bank of Canada's 13F filing for Q1 2025, filed 12 May 2025.